In Vivo Efficacy Testing of Peptide Receptor Radionuclide Therapy Radiosensitization Using Olaparib

SIMPLE SUMMARY: Neuroendocrine tumor (NET) patients often suffer from metastases, thereby eliminating surgery as a curative treatment option. A possible treatment strategy for these patients is peptide receptor radionuclide therapy (PRRT). PRRT is composed of a radiolabeled peptide that can bind to...

Descripción completa

Detalles Bibliográficos
Autores principales: Feijtel, Danny, Reuvers, Thom G. A., van Tuyll-van Serooskerken, Christine, de Ridder, Corrina M. A., Stuurman, Debra C., de Blois, Erik, Verkaik, Nicole S., de Bruijn, Peter, Koolen, Stijn L. W., de Jong, Marion, Nonnekens, Julie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913849/
https://www.ncbi.nlm.nih.gov/pubmed/36765883
http://dx.doi.org/10.3390/cancers15030915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913849/
https://www.ncbi.nlm.nih.gov/pubmed/36765883
http://dx.doi.org/10.3390/cancers15030915

Ejemplares similares